First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 781 000 KRW Market Closed
Updated: May 15, 2024

Samsung Biologics Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samsung Biologics Co Ltd
Operating Expenses Peer Comparison

Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Operating Expenses
-₩689.1B
CAGR 3-Years
-77%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Operating Expenses
-₩17B
CAGR 3-Years
3%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Operating Expenses
-₩37.7B
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Operating Expenses
-₩78.6B
CAGR 3-Years
-27%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Operating Expenses
-₩10B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Operating Expenses
-₩98.6B
CAGR 3-Years
-15%
CAGR 5-Years
-35%
CAGR 10-Years
-30%

See Also

What is Samsung Biologics Co Ltd's Operating Expenses?
Operating Expenses
-689.1B KRW

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Operating Expenses amounts to -689.1B KRW.

What is Samsung Biologics Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-50%

Over the last year, the Operating Expenses growth was -42%. The average annual Operating Expenses growth rates for Samsung Biologics Co Ltd have been -77% over the past three years , -50% over the past five years .